Study Details

Study Purpose

The purpose of this study is to see if the test product (new and not approved by the U.S. Food and Drug Administration [FDA]) is same as the reference product (which is the approved version) by measuring their concentrations in the blood and also to monitor the safety of the study subjects. This study will help to determine how the drug is broken down in the body, to measure the amount of drug in the blood, and to see how long the drug remains in the body.

Study Duration

This study consists of a screening period followed by 4 periods of treatment, 3 (three) ambulatory visits in each period at 36 hrs, 48 hrs and 72 hrs., an End of Study Visit within 6 + 1 days after the last day of dosing and a follow up visit (or phone call) within 30 ± 3 days after the day of the last dosing. There will be at least 7 days interval between each of your administration/study treatment periods.

Study Schedule

General Screening

N/A

Medical Screening

Contact recruitment

Study Visit(s)

Contact recruitment

Follow-Up Visit(s)

Contact recruitment

Other Notes

Bring Valid Photo ID.

Study eligible for referral program. Ask us for details.